Norman Michael Greenberg's most recent trade in Atreca Inc - Ordinary Shares - Class A was a trade of 2,916 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2021 | 2,916 | 9,013 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 17 Mar 2021 | 2,916 | 2,916 (0%) | 0% | 4.6 | 13,297 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 17 Mar 2021 | 2,916 | 0 (0%) | 0% | 16.7 | 48,785 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 17 Mar 2021 | 2,084 | 2,084 (0%) | 0% | 5.2 | 10,753 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 17 Mar 2021 | 2,084 | 0 (0%) | 0% | 16.7 | 34,865 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2021 | 2,084 | 32,915 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 5,000 | 34,999 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.95 per share. | 17 Feb 2021 | 5,000 | 0 (0%) | 0% | 19.0 | 94,752 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 17 Feb 2021 | 5,000 | 5,000 (0%) | 0% | 5.2 | 25,800 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 95,000 | 95,000 | - | - | Employee stock option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.21 per share. | 19 Jan 2021 | 5,000 | 0 (0%) | 0% | 15.2 | 76,045 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 5,000 | 39,999 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 19 Jan 2021 | 5,000 | 5,000 (0%) | 0% | 5.2 | 25,800 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 5,000 | 6,929 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.61 per share. | 17 Dec 2020 | 5,000 | 0 (0%) | 0% | 16.6 | 83,051 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 17 Dec 2020 | 5,000 | 5,000 (0%) | 0% | 4.6 | 22,800 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.34 per share. | 27 Nov 2020 | 3,175 | 0 (0%) | 0% | 15.3 | 48,719 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2020 | 3,175 | 11,929 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 27 Nov 2020 | 3,175 | 3,175 (0%) | 0% | 4.6 | 14,478 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 17 Nov 2020 | 1,825 | 0 (0%) | 0% | 15.0 | 27,448 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 1,825 | 15,104 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 17 Nov 2020 | 1,825 | 1,825 (0%) | 0% | 4.6 | 8,322 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 10 Nov 2020 | 4,500 | 0 (0%) | 0% | 15.1 | 67,963 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 4,500 | 16,929 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 10 Nov 2020 | 4,500 | 4,500 (0%) | 0% | 4.6 | 20,520 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 19 Oct 2020 | 500 | 500 (0%) | 0% | 4.6 | 2,280 | Class A Common Stock |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2020 | 500 | 21,429 | - | - | Stock Option (right to buy) | |
| Atreca Inc Ordinary Shares | Norman Michael Greenberg | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 19 Oct 2020 | 500 | 0 (0%) | 0% | 15.1 | 7,562 | Class A Common Stock |